γ-probe-guided resection of the sentinel lymph node in breast cancer

American Surgeon

Volumn 64, Issue 7, 1998, Pages 666-669

  Crossin, James A ^a,b   Cedric Johnson, A ^a   Stewart, Paul B ^a   Turner Jr , William W ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; PARTIAL MASTECTOMY;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY, MODIFIED RADICAL; MASTECTOMY, SEGMENTAL; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0031799599     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Krag DL, Meiger SJ, Weaver DL, et al. Minimal access surgery for staging malignant melanoma. Arch Surg 1995;130: 654-8.
2. Alex JC, Weaver DL, Fairbank JT, et al. Gamma probe-guided lymph node localization in malignant melanoma. Surg Oncol 1993;3:303-8.
3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
4. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
5. Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8.
6. Davies GC, Millis RR, Hayward JL. Assessment of axillary lymph node status. Ann Surg 1990;192:148-51.
7. Bruneton JN, Caramella E, Hery M, et al. Axillary lymph node metastases in breast cancer. Radiology 1986;158:325-6.
8. Kissin MW, Thompson EM, Price AB, et al. The inadequacy of axillary sampling in breast cancer. Lancet 1982;1:1210-1.
9. Danforth DN, Findlay PA, McDonald HD, et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol 1986;4:655-62.
10. 1b lesions. J Am Coll Surg 1996;183:575-82.
11. 1a breast cancer? J Am Coll Surg 1997;184:493-8.
12. Tobin MB, Lacey HJ, Meyer L, Mortimer DS. The psychological morbidity of breast cancer-related arm swelling. Cancer 1993;72:3248-53.
13. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11:1536-44.
14. Ruffm WK, Stacey-Clear A, Younger J, Hoover HC Jr. Rationale for routine axillary dissection in carcinoma of the breast. J Am Coll Surg 1995;180:245-51.
15. 1a breast carcinoma. Cancer 1994;73: 664-7.
16. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.